THE ART OF MEDICATION MANAGEMENT IN PARKINSON S DISEASE

Similar documents
Issues for Patient Discussion

Optimizing Clinical Communication in Parkinson s Disease:

Best Medical Treatments for Parkinson s disease

Non-Motor Symptoms of Parkinson s Disease

Communicating About OFF Episodes With Your Doctor

Understanding Parkinson s Disease Important information for you and your loved ones

Treatment of Parkinson s Disease: Present and Future

Parkinson s Disease Current Treatment Options

10th Medicine Review Course st July Prakash Kumar

The PD You Don t See: Cognitive and Non-motor Symptoms

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

parts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to

Evaluation and Management of Parkinson s Disease in the Older Patient

Medication Management & Strategies When the levodopa honeymoon is over

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

PARKINSON S MEDICATION

Moving fast or moving slow: an overview of Movement Disorders

The Fresco Institute for Parkinson's and Movement Disorders

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

The PD You Don t See: Cognitive and Non-motor Symptoms

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

Faculty. Joseph Friedman, MD

Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University

Evaluation of Parkinson s Patients and Primary Care Providers

Headway Victoria Epilepsy and Parkinson s Centre

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Multiple System Atrophy

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Parkinson s Disease. Gillian Sare

ARE YOUR LEVODOPA PILLS WORKING LIKE THEY USED TO?

Parkinson s Disease. Sirilak yimcharoen

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

Section 1: What is Parkinson s? Parkinson's Disease Webinar 4/27/2012. April 27th, :00-1:00 PM EST

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH

III./3.1. Movement disorders with akinetic rigid symptoms

Motor Fluctuations in Parkinson s Disease

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Prior Authorization with Quantity Limit Program Summary

DYSKINESIA SYMPTOM TRACKER

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD

Parkinson s disease. Information for patients and carers. The Leeds Teaching Hospitals NHS Trust

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

U n i f i e d P a r k i n s o n s D i s e a s e R a t i n g S c a l e ( U P D R S )

Dr Barry Snow. Neurologist Auckland District Health Board

2-The age at onset of PD is variable, usually between 50 and 80 years, with a mean onset of 55 years (1).

DOCTOR DISCUSSION GUIDE

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

8/28/2017. Behind the Scenes of Parkinson s Disease

DEEP BRAIN STIMULATION SURGICAL CANDIDACY EVALUATION FORM

Drugs used in Parkinsonism

Parkinson s Disease Medications: Professionals Edition

PD: Key Treatment Considerations

Basics of Restless Legs Syndrome (Willis-Ekbom Disease)

Alison Charleston 1 st September 2016

Key Concepts and Issues in Parkinson s Disease in 2016

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

RAMBAM. Revolutionary New Treatment for Parkinson s Disease Tremors. Health Care Campus. Information Guide & Treatment Options

EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS

The Shaking Palsy of 1817

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain.

SPOTLIGHT ON MOVEMENT FUNCTION: COPING WITH ON/OFF PERIODS WELCOME AND INTRODUCTIONS

Enhanced Primary Care Pathway: Parkinson s Disease

05-Nov-15. Impact of Parkinson s Disease in Australia. The Nature of Parkinson s disease 21st Century

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

Parkinson s Disease in 60 minutes. Dr. Claire Hinnell Movement Disorder Neurologist Director Movement Disorder Clinic JPOCSC

MADOPAR 100 mg/25 mg Tablets

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

MEDICATION GUIDE DUOPA (Do-oh-pa) (carbidopa and levodopa) enteral suspension

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

Update on Parkinson s disease and other Movement Disorders October 2018

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

WELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS

Keep moving. Self-help and daily living Keep moving. and answers to your questions about how to exercise if you have arthritis.

Motor symptoms: Tremor: Score (total of four limbs) Absent 0 Symptom not present

The Role of Pharmacists in Treating & Managing Parkinson s Disease Author: Mary Jo Carden, RPh, JD Principal, Carden Associates

XADAGO (safinamide) oral tablet

Parkinson s Disease. Diagnostic Symptoms

Package leaflet: Information for the user

Parkinson s Disease Update

Package leaflet: Information for the patient. Pramipexol Teva Pharma 2.62 mg prolonged-release tablets

Sleep Management in Parkinson s

SINEMET CR Carbidopa-Levodopa

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

Parkinson's Disease and how you can make a difference with medication

History Parkinson`s disease. Parkinson's disease was first formally described in 1817 by a London physician named James Parkinson

Part I Parkinson Disease Diagnosis and Treatment

risk factors for falling

Transcription:

THE ART OF MEDICATION MANAGEMENT IN PARKINSON S DISEASE J O N AT H A N S Q U I R E S, M D, F R C P C C L I N I C A L I N S T R U C T O R, UBC F AC U L T Y O F M E D I C I N E P AC I F I C P AR K I N S O N S R E S E A R C H G R O U P D J AV A D M O W AF A G H I A N C E N T R E F O R B R AI N H E AL T H

DISCLOSURES I have no disclosures relevant to this presentation 2

PARKINSON S DISEASE 101 First described by James Parkinson in his Essay on the Shaking Palsy in 1817 A neurodegenerative condition of unknown cause with 4 cardinal features: Bradykinesia slow, clumsy movements Resting tremor Rigidity of the muscles Balance problems 3

PARKINSON S DISEASE 101 Brain cells (neurons) in a part of the brain called the substantia nigra are slowly lost These neurons make a neurotransmitter called dopamine Loss of dopamine leads to many of the symptoms of Parkinson s disease 4

PARKINSON S DISEASE 101 In addition to the loss of dopamine, cells making other neurotransmitters are also lost: Serotonin Norepinephrine Acetylcholine 5

HOW IS PARKINSON S DISEASE DIAGNOSED? To this day, the only test that can accurately establish a diagnosis of Parkinson s disease is an autopsy Diagnosis is made based on the symptoms and physical exam, with a limited role for diagnostic tests There are a number of conditions that can mimic Parkinson s disease, and at each visit, your neurologist will look for signs that point to one of these mimics as the cause of your symptoms. 6

SYMPTOMS OF PARKINSON S DISEASE Parkinson s disease has a large variety of symptoms that can be broken into 3 broad categories: Pre-motor Motor Non-Motor It is important to keep in mind that no two people with Parkinson s disease are the same, and you will likely not experience many of the symptoms that I will describe 7

PRE-MOTOR SYMPTOMS 5-10 years before the onset of tremor, walking problems or balance issues, many people experience one of more of the following symptoms: Loss of sense of smell/taste Constipation Anxiety and/or depression REM sleep behaviour disorder vivid dreams, acting out dreams These symptoms are believed to be due to the presence of Parkinson s pathology in the olfactory nerves, gut, etc. 8

MOTOR SYMPTOMS These are the classical symptoms of Parkinson s disease Resting tremor shaking when the arm or leg is totally at rest. This initially starts intermittently in one part of the body and then spreads and becomes more continuous Rigidity stiffness of the muscles. Because of this, it is harder to use the muscles and people often feel that their muscles are weak 9

MOTOR SYMPTOMS Bradykinesia slowness of movements. This can manifest as reduced swinging of the arms when you walk, soft speech, small handwriting, reduced facial expression and difficulty with fine motor skills Loss of balance 10

NON-MOTOR SYMPTOMS Parkinson s disease is (unfortunately) more than just tremor! The pathology can be found throughout many parts of the nervous system and can cause many different symptoms. These can be broken down into several categories 11

NON-MOTOR SYMPTOMS: AUTONOMIC The autonomic nervous system regulates the body s housekeeping functions Constipation Delayed gastric emptying bloating Increased frequency and urgency of urination Changes in sweating Lightheadedness when standing up 12

NON-MOTOR SYMPTOMS: PSYCHIATRIC Depression Anxiety Apathy Hallucinations Paranoia 13

NON-MOTOR SYMPTOMS: COGNITIVE Impaired planning and problem-solving Impaired visuospatial skills 14

NON-MOTOR SYMPTOMS: SLEEP REM sleep behaviour disorder vivid dreams, screaming, acting out dreams Sleep fragmentation Daytime sleepiness Fatigue Sleep apnea Restless leg syndrome 15

OTHER NON-MOTOR SYMPTOMS Pain Sensory changes such as numbness and tingling 16

PROGRESSION OF PARKINSON S DISEASE Progression is highly variable from one person to the next Early in the course of the disease, it is impossible to predict how an individual will progress In general, for a given individual, progression tends to be fairly stable If your symptoms worsen abruptly, it is usually a sign that something else is going on 17

TREATMENT OF PARKINSON S DISEASE There is no cure for Parkinson s disease and most available treatments focus on managing the symptoms Since the symptoms and response to treatment vary from person to person, there is no standard recipe for the treatment of the condition. Treatments must be tailored to each individual depending on the challenges they are facing 18

SOME DEFINITIONS Kicking in most people will eventually feel their medication start working anywhere from 15-60 minutes after taking a dose Wearing off when the effect of a dose of medication starts to wane On when your medication is working and your mobility has improved Off when your medication has stopped working (e.g. first thing in the morning or between doses) 19

TREATMENT OF PARKINSON S DISEASE The only treatment that slows the progression of Parkinson s disease is physical activity 30 minutes of moderate intensity exercise 5 times per week Moderate intensity = enough to get your heart rate up a bit and be slightly short of breath, but still able to talk to a workout partner 20

TREATMENT OF PARKINSON S DISEASE There are a number of effective medications available to treat the motor symptoms of Parkinson s disease The goal of treatment is to allow you to live as normal a life as possible for as long as possible 21

NON-PHARMACOLOGICAL TREATMENTS There is good evidence that mind-body techniques have benefit in PD: Yoga Tai Chi Qigong Mindfulness Biofeedback Evidence for benefit of acupuncture is inconclusive 22

PHARMACOLOGICAL TREATMENTS Monoamine oxidase inhibitors COMT inhibitors Dopamine agonists Levodopa Vitamins/Nutraceuticals/Supplements/Cannabis 23

MONOAMINE OXIDASE INHIBITORS Work by preventing dopamine from being broken down by monoamine oxidase Selegiline, rasagiline Can be used alone in early disease, or to increase the effectiveness of levodopa in more advanced disease Reduce off time by about 45 minutes per day Offs are not as deep 24

MONOAMINE OXIDASE INHIBITORS Minimal side effects selegiline can cause insomnia if taken too late in the day Health Canada labeling includes some dietary restrictions that have been removed by the FDA Theoretical interactions with antidepresssants 25

COMT INHIBITORS Slow the breakdown of dopamine by COMT Entacapone Must be taken together with levodopa and extends the duration of effect by 15-30 minutes Main side effects are orange discolouration of the urine and diarrhea 26

DOPAMINE AGONISTS Work by directly stimulating dopamine receptors in the brain Moderate benefit for symptoms Bromocriptine, pramipexole, ropinirole, rotigotine Similar side effects to levodopa, but tend to be a bit more severe with agonists 27

DOPAMINE AGONSITS Compared to levodopa, there is a higher risk of developing impulse control disorders 10% of people taking dopamine agonists, higher risk at higer doses Compulsive gambling, shopping, eating, hypersexuality (including pornography), use of the internet Increase in goal-directed (but purposeless) activity, such as collecting and sorting objects, rearranging furniture, cleaning, etc. Can be associated with changes in posture such as leaning to one side (Pisa syndrome) or extreme flexion at the waist (camptocormia) Reports of sleep attacks (caution regarding driving), though these are rare 28

AMANTADINE Complex mechanism of action, working on multiple different neurotransmitters Originally developed to treat the flu in the 1960s Predominantly used to treat dyskinesias, but can also have some benefit for tremor and stiffness Side effects: constipation, dry mouth/eyes, rash, ankle swelling*, hallucinations* * = need to stop the medication 29

LEVODOPA Converted to dopamine by the body and acts as a replacement for the dopamine that is no longer being produced in the brain Combined with another drug (carbidopa or benserazide) to prevent the conversion until it reaches the brain Still the gold standard for the treatment of the motor complications of Parkinson s disease 30

LEVODOPA Side effects include nausea, fatigue, lightheadedness when you stand, hallucinations and problems with impulse control (the last two are less common than with dopamine agonists) Because it is the most effective treatment, almost everyone with Parkinson s disease will eventually need to go on levodopa 31

ADVANCED THERAPIES For individuals who cannot achieve acceptable control of their symptoms with oral medications, two advanced therapies are available in Canada: Levodopa/cariboda intestinal gel (Duodopa) Deep brain stimulation (DBS) 32

SUPPLEMENTS The following supplements have been found to be ineffective in studies: Creatine Coenzyme Q10 Vitamin E Small trials of intranasal glutathione have shown a slight benefit on the motor symptoms of Parkinson s disease 33

SUPPLEMENTS Mucuna pruriens extract contains levodopa and has demonstrated benefit for the motor symptoms of Parkinson s disease with fewer side effects studies have all been short term (single doses) and involved small numbers of participants 34

CANNABIS The available evidence is of poor quality The results are contradictory Currently, cannabis and its derivatives are not recommended in the treatment of Parkinson s disease, but research is ongoing 35

MOTOR COMPLICATIONS OF PARKINSON S DISEASE When treatment is first started for Parkinson s disease, people experience a so-called honeymoon period where response to treatment is smooth without any off time. As time passes, a combination of changes in the brain due to disease progression and the treatments for the disease, a number of motor complications arise Broken into two categories: fluctuations and dyskinesias 36

MOTOR FLUCTUATIONS Wearing off Sudden offs Random offs Super offs Delayed kicking in Dose failures Freezing of gait (FOG) Off dystonia 37

WEARING OFF Generally begins as end-of-dose failure Practical definition <4 hour duration of an adequate dose of levodopa Early in disease, healthy neurons are able to take up and store levodopa and release it later when it is needed, so the effect of each dose persists despite a drop in blood levels of levodopa 38

WEARING OFF As the disease progresses, there are fewer healthy neurons left to store the drug, and this long-duration response is lost Each dose of levodopa only lasts 1.5 2 hours, so as the disease progresses, you need more doses of the medication This does not mean that the medication stops working, but is largely due to changes in the brain due to disease progression 39

WEARING OFF Sudden offs are those that occur over a period of minutes, as opposed to the slow wearing off that is usually seen Random offs can occur at any time. Some people will kick back in again without having to take another dose of medication Super offs are periods when you feel worse than if you were not on any medication It is unknown how/why these occur 40

WEARING OFF There are many options available to treat wearing off, each with their own advantages and disadvantages: Higher doses of medication More frequent doses of medication Adding a medication to extend the duration of a dose (e.g. adding entacapone to levodopa) Adding a different type of medication Adding a longer-acting formulation of an existing medication (e.g. levodopa/carbidopa CR) 41

OFF-PERIOD DYSTONIA Dystonia is a contraction of muscles leading to abnormal postures Commonly manifests as leg cramping or toe curling in the early morning when medication levels are at their lowest 42

DELAYED KICKING IN Defined as taking >30 minutes for a dose of levodopa to start working At its most extreme, the dose fails to kick in at all Especially common for the first AM dose Due to any or all of: Delayed gastric emptying Constipation Poor absorption due to competition with dietary protein 43

FREEZING OF GAIT The inability to move your feet to start walking despite the attempt to do so Usually begins with start hesitation freezing when you first start to walk More common in narrow spaces and when under stress 44

NON-MOTOR FLUCTUATIONS As with the motor symptoms, almost any of the non-motor symptoms of Parkinson s disease can fluctuate with the level of your medication For example, some people become very anxious a short time before a dose of medication is due, with the anxiety improving when the next dose kicks in Non-motor symptoms can fluctuate even if the motor symptoms don t 45

MARTINEZ-FERNANDEZ ET. AL. MOV DISORD 2016: 1-15 46

DYSKINESIAS Involuntary fidgety movements related to medication Can be caused by almost any of the medications used to treat Parkinson s, but more likely with levodopa Can occur in two patterns: Peak dose: when the blood levels of the medication are their highest Diphasic: as the medication is just kicking in or wearing off 47

THE DRUGS DON T WORK Some symptoms may take higher doses of medication to treat than others Tremor and freezing can be particularly resistant to medication, so it can seem like the medication isn t doing anything Medications are best for muscle rigidity and slowness and clumsiness of movements (bradykinesia) Increasing medications to treat the symptoms may worsen others and increase side effects 48

RISK FACTORS FOR FLUCTUATIONS AN DYSKINESIAS Even though these problems are common, there is not much research on how common they are or what factors may contribute to developing them The available evidence suggests that after 5 years of treatment for Parkinson s disease: Around 52% of people have fluctuations (42%), dyskinesias (24%), or both 49

RISK FACTORS FOR FLUCTUATIONS AND DYSKINESIAS Known risk factors for fluctuations and dyskinesias include: Younger age at diagnosis Being a woman Longer duration of Parkinson s disease More severe disease Higher total daily dose of levodopa 50

THE ROLE OF LEVODOPA In the past, we used to avoid using levodopa for as long as possible because it was felt to delay the onset of the motor complications In recent years it has become clear that the risk of complications is related to higher total daily doses of levodopa, and delaying treatment does not significantly delay the onset of the complications as long as the dose of medications is kept as low as possible 51

Cilia et. al. Brain 2014: 137; 2731 2742 52

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? In general, Parkinson s disease progresses slowly without significant changes in symptoms over the short term (though there will be good days and bad days) Symptoms that worsen fairly suddenly over a couple of days are an indicator that something else is going on Poor sleep Bladder or other infection Interaction between your Parkinson s medications and a new drug Other medical issues Worsening of Parkinson s symptoms may be the only symptom of the other problem See your family doctor! 53

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? Exercise is an effective treatment for Parkinson s disease and many of the symptoms that are associated with it: Fatigue Depression and anxiety Prevention of cognitive/memory problems Prevention of falls Consider a Parkinson s-specific exercise program or see a trainer or physiotherapist to tailor an exercise program to your needs 54

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? We still do not know what the best exercise is or how long or how hard to do it for The current recommendation is 30 minutes of moderate intensity activity, 5 times per week Try to incorporate some stretching, core strengthening and balance exercises into your routine 55

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? It remains to be seen if there is a best exercise for Parkinson s disease Even if there is, if you don t like the best exercise, you won t do it, so find something that you enjoy and do that 56

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? If you are experiencing delayed kicking in: See if spacing your medication 30-60 minutes from high-protein food helps This includes dairy products, eggs, soy products like tofu, peanut and nut butters in addition to meat and fish Take your medication with an acidic beverage, like orange juice or club soda If you are on levodopa, you can try chewing ½ - 1 tab and swallowing the rest NB chewing CR levodopa changes it to IR, so it may not last as long 57

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? Managing constipation can make a big difference in how long your medication lasts and how long it takes to kick in you can t absorb your medication as well when you are constipated Stay hydrated (2 L of water per day, mostly between waking up in the morning and supper) Exercise! (Core exercises help too) Coffee Take a daily laxative (or two): senna tea, PEG, magnesium citrate, etc Aim for a soft bowel movement without straining every time you go 58

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? If you are having dyskinesias, keep track of when they occur in relation to your medication times As mentioned, there are two types of dyskinesias Peak dose Diphasic You may have both types They may look the same, but the treatment is different, so the timing matters! 59

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? With any bothersome symptom, it is worthwhile keeping a diary for a week or two, noting what time the symptom occurs, when you take your medications, when you eat your meals, and any other relevant details (were you sick? Did you sleep poorly the night before?) As mentioned, some symptoms can be related to Parkinson s disease OR the medications used to treat it The timing is important in helping your doctor figure out which it is 60

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? If you are experiencing freezing of gait, keep track of whether it is occurring when you are on or off Often physiotherapy is more effective than medications for this problem When you freeze, stop and take a deep breath and try again Counting or singing in your head, trying to step over a line on the floor, your partner s foot or other obstacle can help overcome the freeze 61

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? If you are falling, what is making you fall? Freezing? Are you feeling lightheaded? Are you falling while turning or backing up? Are you losing your balance? Do you fall more when you are on or off? Are dyskniesias throwing you off balance? 62

WHAT CAN YOU DO ABOUT BOTHERSOME SYMPTOMS? Parkinson s disease is complicated and can affect multiple organ systems, and it is often unclear whether symptoms that you experience are related to Parkinson s, your medication, or something else entirely Non-motor symptoms are treated the same as they would be if you didn t have Parkinson s disease. Your family doctor is often better qualified to manage these than your neurologist 63